Read the founding story of the Sloan-Kettering Institute for Cancer Research, named after longtime General Motors CEO Alfred P. Sloan and research director Charles Kettering.

An outline of the discovery of imatinib (Gleevec), a ground-breaking drug that transformed the treatment of chronic myelogenous leukemia and sparked the beginning of precision medicine.

The explosive growth of life sciences data is driving artificial intelligence methods to gain traction in biology and medicine — including cancer research.

While cancer remains incurable, there's been so much progress in its treatment over the last two decades. Nature provides an abridged history of milestones and major triumphs in cancer research and treatment. Start in the year 2000, and see how much has changed in the first quarter of the new millennium

The American Association for Cancer Research's "Snapshot of a Year of Progress" offers an overview of significant advancements in cancer research and treatment over the past year. Take a quick look at the rapid pace of scientific discovery and the translation of research findings into clinical practice. In 2024 alone, health regulators approved 15 new anticancer therapies alone.

When IBM’s Deep Blue supercomputer won its famous chess rematch with then world champion Garry Kasparov in May 1997, the victory was hailed far and wide as a triumph of artificial intelligence. But John McCarthy—the man who coined the term and pioneered the field of AI research—didn’t see it that way. An obituary about McCarthy—who passed in 2001—and his ideas.

KJ Muldoon had a 50% chance of surviving a genetic mutation until doctors developed a one-of-a-kind gene-editing therapy. In an interview with one of the researchers behind the treatment, learn what it will take to make personalized genetic medicine possible for everyone.

While new treatments for cancer are under continuous development, researchers are increasingly using engineering principles to find wholly new strategies to combat the disease. Directions include nanoparticle drug delivery, advanced imaging tools, developing new materials to interact with cells, tissue engineering, robotic surgeries, and more. Such interdisciplinary efforts are expected to unlock new tools and therapies beyond traditional drug formulation.

In the 1950s, William Shockley led the way in the semiconductor business. Everything changed in 1957, after eight of his engineers—whom he called the "Traitorous Eight"—left his company to start their own. Their company, named Fairchild Semiconductor, employed many future founders of major Silicon Valley companies. Today, the Traitorous Eight are considered among the founders of Silicon Valley.

Koch was one of the first scientists to isolate the bacterium that causes cholera while investigating an outbreak in Egypt in 1883. He went on to advise about rules to control cholera outbreaks, which formed the basis of the disease control approaches and water hygiene techniques still used today.

Despite their 16-year age difference, legendary inventor Thomas Edison and Henry Ford developed a close relationship after meeting at a convention in New York. The two—alongside environmentalist John Burroughs and Harvey Firestone, the founder of Firestone Tire—were known as the "Four Vagabonds" and were famous for their long roadtrips, which were often highly publicized.

Memorial Sloan Kettering Cancer Center has created this searchable resource of herbal supplements to inform the public about the purported uses of herbal therapies, the existing evidence about them, their mechanism of action, and any concerns about potential herbal supplement and drug interactions.

Led by CEO Sam Altman, OpenAI's mission is to "ensure artificial general intelligence benefits all of humanity" by making its products open to all users. In 2023, the $86B company behind the chatbot ChatGPT consisted of a for-profit arm under its nonprofit governing board.

OpenAI was originally created as a nonprofit to develop artificial general intelligence for humanity's benefit. However, skyrocketing computing costs made adherence to this belief difficult, as new influences, such as external investors, were introduced to accelerate growth with reduced safety.

This documentary argues that GM systematically bought up and destroyed streetcar networks across the US in the 1930s, replacing them with buses and helping put the automobile at the center of American culture.

A trio of scientists won the Nobel in Physiology or Medicine that year, but they performed their award-worthy work beginning about two decades before winning the prize. This announcement includes details about the science and notes that the three scientists will equally share the 11 million Swedish kronor (almost $1.2M).

The 2025 Nobel Prize was awarded to scientists who discovered how immune system soldiers are typically stopped from attacking healthy tissue. The work furthered autoimmune understanding and cancer therapies.

Stanford University professor Frederick Terman used to encourage his students to start their own tech companies. His advice led to the creation of Hewlett-Packard. He also established the Stanford Research Park, which helped develop many successful tech companies today. Terman is often called the "Father of Silicon Valley," because his ideology directly shaped the region's development.

Before World War II, research institutions were funded by endowments or private companies whose priorities stifled the curiosity-driven science that fueled significant breakthroughs and innovation. The NSF was established in 1950 to promote independent scientific progress through basic research, which is focused on knowledge acquisition rather than commercial applications, conducted at national colleges and universities.

Daniel Ha is a venture capitalist who built a suite of AI agents to boost his productivity, both professionally and personally. At his VC firm, a troupe of agents gathers data on startups and analyzes it from competing perspectives to produce a confidence score. When his dad was diagnosed with cancer, Ha used an oncology-trained AI to help him understand the condition.

A study shows trametinib and rapamycin, two drugs used for cancer treatment in humans, increased mouse lifespan when used together. The medications delayed the onset of cancer and reduced chronic inflammation, results that will be explored in future research.